Search

BIOHIT HealthCare and the British Laryngological Association agree to corporate partnership

BIOHIT HealthCare is pleased to announce its corporate partnership with the British Laryngological Association (BLA) for 2022-2023, which brings together two organisations with the mission to advance laryngology diagnostics.

BIOHIT HealthCare is exhibiting at the BSI congress 2022

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

Wraparound IBD care pathway for enhanced patient outcomes

BIOHIT HealthCare is pleased to announce its partnership with Celltrion Healthcare UK Ltd, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to seamlessly support patients with inflammatory bowel disease (IBD) and their healthcare providers.

MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs

The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London.

Innovative Digital Operating Theatres from KARL STORZ

A major project with the Hospital Alemán in Buenos Aires, Argentina, shows that KARL STORZ's complete solutions for operating theaters, known as OR1™, enjoy a great reputation worldwide.

May 3rd is Good Vibrations Day | Bone Anchored Awareness Day

Oticon Medical will celebrate the fourth annual Good Vibrations Day/Bone Anchored Awareness Day on May 3rd, 2024.

KARL STORZ Gains Approval for Solo+™ Revolutionary Ear Tube Placement Device

Chronic ear infections are a leading reason for doctor visits and surgical procedures such as placement of ear tubes in young children.

Neuromod closes €10 million financing to accelerate commercialisation

Neuromod, an Irish medical device company specialising in tinnitus, has closed a €10 million equity financing deal in a Series B fundraising expansion to expand the availability of tinnitus treatment device, Lenire. Financing was oversubscribed and led by existing investors...

Leightons and The Hearing Care Partnership Opens Registration for Groundbreaking New Clinical Conference: Oxygen 2025

Leightons Opticians & Hearing Care is excited to announce that registration is now open for Oxygen 2025, a pioneering clinical conference taking place on the 9th and 10th of May 2025. This highly anticipated event, hosted by the leading independent,...

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...